Navarro Gemma, Aymerich Marisol S, Marcellino Daniel, Cortés Antoni, Casadó Vicent, Mallol Josefa, Canela Enric I, Agnati Luigi, Woods Amina S, Fuxe Kjell, Lluís Carmen, Lanciego Jose Luis, Ferré Sergi, Franco Rafael
Institut d'Investigacions Biomèdiques August Pi i Sunyer, Centro de Investigación Biomédica en Red Sobre Enfermedades Neurodegenerativas, and Department of Biochemistry and Molecular Biology, Faculty of Biology, University of Barcelona, 08028 Barcelona, Spain.
Centro de Investigación Médica Aplicada Neurociencias (CIMA), Universidad de Navarra, Avda. Pio XII 55, 31008 Pamplona, Spain.
J Biol Chem. 2009 Oct 9;284(41):28058-28068. doi: 10.1074/jbc.M109.034231. Epub 2009 Jul 24.
The Ca(2+)-binding protein calmodulin (CaM) has been shown to bind directly to cytoplasmic domains of some G protein-coupled receptors, including the dopamine D(2) receptor. CaM binds to the N-terminal portion of the long third intracellular loop of the D(2) receptor, within an Arg-rich epitope that is also involved in the binding to G(i/o) proteins and to the adenosine A(2A) receptor, with the formation of A(2A)-D(2) receptor heteromers. In the present work, by using proteomics and bioluminescence resonance energy transfer (BRET) techniques, we provide evidence for the binding of CaM to the A(2A) receptor. By using BRET and sequential resonance energy transfer techniques, evidence was obtained for CaM-A(2A)-D(2) receptor oligomerization. BRET competition experiments indicated that, in the A(2A)-D(2) receptor heteromer, CaM binds preferentially to a proximal C terminus epitope of the A(2A) receptor. Furthermore, Ca(2+) was found to induce conformational changes in the CaM-A(2A)-D(2) receptor oligomer and to selectively modulate A(2A) and D(2) receptor-mediated MAPK signaling in the A(2A)-D(2) receptor heteromer. These results may have implications for basal ganglia disorders, since A(2A)-D(2) receptor heteromers are being considered as a target for anti-parkinsonian agents.
钙结合蛋白钙调蛋白(CaM)已被证明可直接结合某些G蛋白偶联受体的细胞质结构域,包括多巴胺D(2)受体。CaM与D(2)受体长的第三个细胞内环的N端部分结合,位于一个富含精氨酸的表位内,该表位也参与与G(i/o)蛋白和腺苷A(2A)受体的结合,并形成A(2A)-D(2)受体异聚体。在本研究中,通过蛋白质组学和生物发光共振能量转移(BRET)技术,我们提供了CaM与A(2A)受体结合的证据。通过使用BRET和顺序共振能量转移技术,获得了CaM-A(2A)-D(2)受体寡聚化的证据。BRET竞争实验表明,在A(2A)-D(2)受体异聚体中,CaM优先结合到A(2A)受体的近端C端表位。此外,发现Ca(2+)可诱导CaM-A(2A)-D(2)受体寡聚体的构象变化,并选择性调节A(2A)-D(2)受体异聚体中A(2A)和D(2)受体介导的MAPK信号传导。这些结果可能对基底神经节疾病有影响,因为A(2A)-D(2)受体异聚体正被视为抗帕金森病药物的靶点。